Herlenius Gustaf, Hansson Sverker, Krantz Marie, Olausson Michael, Kullberg-Lindh Carola, Friman Styrbjörn
Transplant Institute, Sahlgrenska University Hospital, Göteborg, Sweden.
Pediatr Transplant. 2010 May;14(3):409-16. doi: 10.1111/j.1399-3046.2010.01301.x. Epub 2010 Mar 17.
Long-term exposure to calcineurin inhibitors increases the risk of CKD in children after LT. The aims of this study were to study renal function by measuring GFRm before and yearly after LT, to describe the prevalence of CKD (stage III: GFR 30-60 mL/min/1.73 m(2)) and to investigate if age and underlying liver disease had an impact on long-term renal function. Thirty-six patients with a median age of 2.9 years (0.1-16 yr) were studied. Median follow-up was 6.5 (2-14 yr). GFRm decreased significantly during the first six months post-transplantation with 23% (p < 0.001). Thereafter renal function stabilized. At six months, 17% (n = 5) of the children presented CKD stage III and at five yr the prevalence of CKD III was 18% in 29 children. However, in 13 children with a 10-year follow-up it was 0%. None of the children required renal replacement therapy after LT. When analyzing renal function of those children younger than two yr (n = 14) and older than two yr (n = 17) at the time of transplantation, we found that in both cohorts the filtration rate remained remarkably stable during the five-yr observational period. However, there was a statistically significant (p < 0.05) difference in the percentual decrease in GFRm between the groups during the first six months after LT 13% and 31%, respectively. Baseline GFRm according to diagnosis did not differ between the groups. During the first six months after LT, patients transplanted for hepatic malignancy (n = 6) and those with metabolic liver disease (n = 4) had a percentage loss of GFRm of 32% and 35%, respectively. The corresponding loss of GFRm in patients with other diseases was 10-19%. Six months post-transplantation mean GFRm in the group with malignant liver disease was 65 +/- 15 mL/min/1.73 m(2) and in the group with other diseases (n = 24) 82 +/- 17 mL/min/1.73 m(2) (p < 0.05). At one, three and five yr post-transplantation there was no longer a statistically significant difference between these cohorts. Our findings suggest that there can be a long-term recovery of renal function after LT in children.
长期暴露于钙调神经磷酸酶抑制剂会增加儿童肝移植后发生慢性肾脏病(CKD)的风险。本研究的目的是通过在肝移植前及移植后每年测量肾小球滤过率(GFRm)来研究肾功能,描述CKD(Ⅲ期:GFR 30 - 60 mL/min/1.73 m²)的患病率,并调查年龄和潜在肝脏疾病是否对长期肾功能有影响。研究了36例患者,中位年龄为2.9岁(0.1 - 16岁)。中位随访时间为6.5年(2 - 14年)。移植后前六个月GFRm显著下降23%(p < 0.001)。此后肾功能稳定。六个月时,17%(n = 5)的儿童出现CKDⅢ期,五年时,29例儿童中CKDⅢ期的患病率为18%。然而,在13例随访10年的儿童中,患病率为0%。肝移植后没有儿童需要肾脏替代治疗。分析移植时年龄小于2岁(n = 14)和大于2岁(n = 17)的儿童的肾功能时,我们发现两个队列在五年观察期内滤过率均保持相当稳定。然而,肝移植后前六个月两组之间GFRm的下降百分比存在统计学显著差异(p < 0.05),分别为13%和31%。根据诊断,两组的基线GFRm无差异。肝移植后前六个月,因肝脏恶性肿瘤移植的患者(n = 6)和患有代谢性肝病的患者(n = 4)GFRm的损失百分比分别为32%和35%。其他疾病患者GFRm的相应损失为10 - 19%。移植后六个月,肝脏恶性疾病组的平均GFRm为65 ± 15 mL/min/1.73 m²,其他疾病组(n = 24)为82 ± 17 mL/min/1.73 m²(p < 0.05)。移植后1年、3年和5年,这些队列之间不再有统计学显著差异。我们的研究结果表明,儿童肝移植后肾功能可能会有长期恢复。